Ivabradine and the SIGNIFY conundrum. - Wikidata - awgldk - TriplyDB

Ivabradine and the SIGNIFY conundrum.

Ivabradine and the SIGNIFY conundrum.

http://www.wikidata.org/entity/Q54546642

about

The Role of Ivabradine in the Management of Angina Pectoris.

P2860

Q37298004-E3F6513B-02B9-42A4-B44E-BB4ABB426ADA

P2860

Ivabradine and the SIGNIFY conundrum.

http://www.wikidata.org/entity/Q54546642

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Ivabradine and the SIGNIFY conundrum.

@en

Ivabradine and the SIGNIFY conundrum.

@nl

type

label

Ivabradine and the SIGNIFY conundrum.

@en

Ivabradine and the SIGNIFY conundrum.

@nl

prefLabel

Ivabradine and the SIGNIFY conundrum.

@en

Ivabradine and the SIGNIFY conundrum.

@nl

P1433

Q54546642-06450B9B-BCC0-4564-BFFE-92A03B1A129F

P1476

Q54546642-2A2D02F5-8361-4CF2-B820-FE119B9DD447

P2093

Q54546642-C60D1B42-A5B2-4A90-8DF2-487DC33C88B8

P2860

Q54546642-00E06159-162C-4633-A235-E88EFB4ABDC2

Q54546642-1459499B-E372-4A00-BA5D-721E75AD6F55

Q54546642-58F73C9F-418A-468C-AD13-36F2D3521F11

Q54546642-7C19C091-5E7D-4C77-8C38-D42DEEA92D9E

Q54546642-98912261-7CCB-4518-9BEC-1EEA1671F6E3

Q54546642-A64ED99C-6214-4E3C-9822-B4A984A45FD0

Q54546642-B112C258-3185-43BE-914C-C3E13FF82DF0

Q54546642-C39A3081-B2EA-4291-9D7C-09E681E16871

Q54546642-D9578B52-2DB0-45FD-9771-B8D142B9B084

Q54546642-DF081DB6-522E-4119-BDEE-730091988A2B

P304

Q54546642-D7F35185-C6CE-4BA6-AF5F-BC235F49840C

P31

Q54546642-39AFD107-E4A7-4532-950E-04BF964BADD6

Q54546642-69727b73-1f6b-476e-ac1d-d5358d878468

P356

Q54546642-58142624-54B2-4BF4-9957-7CB5B7387967

P433

Q54546642-B73A4630-26EB-4DB7-9E44-29499AF97620

P478

Q54546642-511BC9C2-5B00-4495-8FD1-B09CB242E4E3

P577

Q54546642-CECC9AD9-15AB-4E3D-9914-D128BE5C5CEB

P698

Q54546642-C842A222-9ED4-4EDD-A994-A86025549EEF

P356

P1433

European Heart Journal

P1476

Ivabradine and the SIGNIFY conundrum.

@en

P2093

John F Beltrame

http://www.w3.org/2001/XMLSchema#string

P2860

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

Torsades de pointes induced by the concomitant use of ivabradine and azithromycin: an unexpected dangerous interaction.

Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial.

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.

hERG potassium channel blockade by the HCN channel inhibitor bradycardic agent ivabradine.

I f inhibition with ivabradine : electrophysiological effects and safety.

Selective and specific inhibition of If with ivabradine for the treatment of coronary artery disease or heart failure.

Mibefradil: "Has the baby been thrown out with the bath water?".

The prevalence of weekly angina among patients with chronic stable angina in primary care practices: The Coronary Artery Disease in General Practice (CADENCE) Study.

Ivabradine in stable coronary artery disease without clinical heart failure.

P304

3297-3299

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/EURHEARTJ/EHV368

http://www.w3.org/2001/XMLSchema#string

P433

46

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P577

2015-08-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26264551

http://www.w3.org/2001/XMLSchema#string